iRay Technology Future Growth
Future criteria checks 5/6
iRay Technology is forecast to grow earnings and revenue by 26.8% and 21.6% per annum respectively. EPS is expected to grow by 27.2% per annum. Return on equity is forecast to be 18.1% in 3 years.
Key information
26.8%
Earnings growth rate
27.2%
EPS growth rate
| Medical Equipment earnings growth | 23.6% |
| Revenue growth rate | 21.6% |
| Future return on equity | 18.1% |
| Analyst coverage | Good |
| Last updated | 10 Sep 2024 |
Recent future growth updates
Recent updates
iRay Technology (SHSE:688301) Might Be Having Difficulty Using Its Capital Effectively
Sep 27
iRay Technology's (SHSE:688301) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 26iRay Technology Company Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Apr 23Are iRay Technology Company Limited (SHSE:688301) Investors Paying Above The Intrinsic Value?
Apr 11Slowing Rates Of Return At iRay Technology (SHSE:688301) Leave Little Room For Excitement
Mar 21With iRay Technology Company Limited (SHSE:688301) It Looks Like You'll Get What You Pay For
Feb 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3,321 | 1,197 | 1,585 | 1,337 | 5 |
| 12/31/2025 | 2,851 | 1,004 | 425 | 1,177 | 8 |
| 12/31/2024 | 2,272 | 783 | 58 | 476 | 5 |
| 6/30/2024 | 1,933 | 590 | -1,556 | 416 | N/A |
| 3/31/2024 | 1,914 | 610 | -1,738 | 339 | N/A |
| 12/31/2023 | 1,864 | 607 | -1,513 | 340 | N/A |
| 9/30/2023 | 1,842 | 566 | -975 | 286 | N/A |
| 6/30/2023 | 1,786 | 689 | -903 | 314 | N/A |
| 3/31/2023 | 1,663 | 677 | -725 | 242 | N/A |
| 12/31/2022 | 1,549 | 641 | -401 | 317 | N/A |
| 9/30/2022 | 1,468 | 666 | -210 | 299 | N/A |
| 6/30/2022 | 1,352 | 551 | -28 | 270 | N/A |
| 3/31/2022 | 1,291 | 510 | -57 | 214 | N/A |
| 12/31/2021 | 1,187 | 484 | 56 | 248 | N/A |
| 9/30/2021 | 1,054 | 392 | 192 | 243 | N/A |
| 6/30/2021 | 955 | 322 | 244 | 293 | N/A |
| 3/31/2021 | 872 | 265 | 285 | 307 | N/A |
| 12/31/2020 | 784 | 222 | 245 | 262 | N/A |
| 9/30/2020 | 787 | 218 | 128 | 144 | N/A |
| 6/30/2020 | 730 | 180 | 49 | 82 | N/A |
| 3/31/2020 | 581 | 116 | 10 | 49 | N/A |
| 12/31/2019 | 546 | 96 | -9 | 31 | N/A |
| 12/31/2018 | 439 | 61 | -28 | 19 | N/A |
| 12/31/2017 | 356 | 54 | N/A | 102 | N/A |
| 12/31/2016 | 256 | 43 | N/A | 40 | N/A |
| 12/31/2015 | 213 | 19 | N/A | 63 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688301's forecast earnings growth (26.8% per year) is above the savings rate (2.9%).
Earnings vs Market: 688301's earnings (26.8% per year) are forecast to grow faster than the CN market (22.9% per year).
High Growth Earnings: 688301's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688301's revenue (21.6% per year) is forecast to grow faster than the CN market (13.1% per year).
High Growth Revenue: 688301's revenue (21.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688301's Return on Equity is forecast to be low in 3 years time (18.1%).